Exelixis, Inc. (Nasdaq: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of ...

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market" report has been added to ResearchAndMarkets.com's offering. The global demand for advanced carcinoid tumor treatments is ...

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market" report has been added to ResearchAndMarkets.com's offering. The global demand for advanced carcinoid tumor treatments is ...

Teddi Mellencamp’s doctors discovered more tumors in her body after she underwent emergency brain surgery last month. The "Real Housewives of Beverly Hills" star shared a health update on her ...

Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. In a cohort of patients with liver metastases ...

The website provides information about neuroendocrine cancer and patient stories. It has many other resources and links. The Carcinoid Cancer Foundation is an American organisation that encourages and ...

Tumor lysis syndrome can occur when a patient’s body is not able to clear away waste released by dead cancer cells quickly enough after treatment for chronic lymphocyctic leukemia (CLL). Certain ...

4 Midgut tumors are frequently diagnosed incidentally, but can also be diagnosed on the basis of the symptoms of carcinoid syndrome, or following presentation with intestinal obstruction.

Aim/introduction: Peptide receptor radionuclide therapy (PRRT) is an effective and well-tolerated treatment option for patients with neuroendocrine tumors (NETs) that prolongs progression-free ...

It isn’t easy to cope with carcinoid syndrome. People often think they have an idea of what having cancer is like, but NETs are different from other cancers. You might have ongoing symptoms and ...